Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iterum Therapeutics (ITRM) Return on Invested Capital (2018 - 2022)

Historic Return on Invested Capital for Iterum Therapeutics (ITRM) over the last 5 years, with Q3 2022 value amounting to 0.75%.

  • Iterum Therapeutics' Return on Invested Capital fell 3400.0% to 0.75% in Q3 2022 from the same period last year, while for Sep 2022 it was 0.75%, marking a year-over-year decrease of 3400.0%. This contributed to the annual value of 2.18% for FY2021, which is 34000.0% down from last year.
  • Latest data reveals that Iterum Therapeutics reported Return on Invested Capital of 0.75% as of Q3 2022, which was down 3400.0% from 0.63% recorded in Q2 2022.
  • In the past 5 years, Iterum Therapeutics' Return on Invested Capital ranged from a high of 11.05% in Q4 2019 and a low of 13.88% during Q1 2021
  • For the 5-year period, Iterum Therapeutics' Return on Invested Capital averaged around 0.56%, with its median value being 0.51% (2018).
  • As far as peak fluctuations go, Iterum Therapeutics' Return on Invested Capital tumbled by -176600bps in 2021, and later surged by 135000bps in 2022.
  • Iterum Therapeutics' Return on Invested Capital (Quarter) stood at 0.85% in 2018, then skyrocketed by 1401bps to 11.05% in 2019, then crashed by -92bps to 0.89% in 2020, then tumbled by -149bps to 0.44% in 2021, then plummeted by -71bps to 0.75% in 2022.
  • Its Return on Invested Capital stands at 0.75% for Q3 2022, versus 0.63% for Q2 2022 and 0.38% for Q1 2022.